Jim Cramer – Page 3 – Finance Tailwind

How Goldman Sachs aims to dominate another corner of Wall Street

Wall Street analysts rush to Eli Lilly’s defense but investors aren’t listening

Texas Roadhouse’s mixed results capture the conundrum this stock has become

We’re downgrading Lilly and asking ourselves tough questions after its obesity

We’re upgrading our rating on Disney thanks to a misguided market reaction to

Coterra’s earnings beat doesn’t change the big picture for the oil producer

We’re lowering our price target on Bristol Myers as two key overhangs persist

We’re reiterating our rating on Amazon as shares fall in the after hours

We own Linde to deliver in tough times. It didn’t disappoint this quarter

Apple’s killer quarter buys more time for the company to deliver clarity on AI